Nutritional Growth Solutions (ASX: NGS) has secured a $2.5 million placement and moved closer to acquiring Sprout Organic, aiming to boost revenue and cut costs amid improved cash flow.
- Sprout Organic acquisition announced for A$8 million via share issue
- A$2.5 million placement secured to fund growth and integration
- Operating cash outflows halved to US$195k with inventory investment
- Debt-free balance sheet maintained with US$290k cash on hand
- Acquisition expected to deliver A$870k in annualised cost savings
Sprout Organic Acquisition and Capital Raise
Nutritional Growth Solutions (ASX:NGS) is gearing up for a transformational step with its announced acquisition of Sprout Organic Pty Ltd for approximately A$8 million. The deal, struck on 25 May 2026, involves issuing shares at a deemed price of A$0.02 per share, pending shareholder approval at the upcoming Annual General Meeting. To support Sprout's working capital ahead of completion, NGS advanced an unsecured, interest-free loan of US$225,000 during the quarter, which will be eliminated on consolidation once the acquisition closes.
Alongside the acquisition, NGS secured firm commitments for a A$2.5 million placement of 125 million shares at the same issue price, designed to fund working capital, inventory expansion, sales and marketing, and integration costs. This capital raise, also subject to shareholder approval, is seen as highly likely to complete, positioning the company to strengthen its product portfolio and revenue base.
Improved Cash Flow and Operating Performance
The quarter ending 30 June 2026 marked a significant improvement in NGS's cash flow dynamics. Net operating cash outflows more than halved to US$195,000, down 54% from US$426,000 in the prior quarter. This reduction reflects the full impact of structural cost reductions implemented from February 2026, trimming approximately US$600,000 annually. The remaining outflow largely stems from a deliberate inventory build to ensure full product availability ahead of anticipated sales growth.
Customer receipts remained stable at US$338,000, supported by full inventory availability and steady demand across the existing customer base. The company continues to operate with a lean cost base aligned with its restructured model, which management views as a foundation for sustainable growth.
Debt-Free Balance Sheet and Financial Position
NGS maintained a debt-free balance sheet throughout the quarter, with no outstanding loan facilities or credit arrangements. Cash on hand stood at US$290,000 after factoring in the advance to Sprout Organic. The company also completed final repayments totaling US$7,000 on a directors' and officers' insurance premium funding arrangement, fully closing this facility.
Payments to related parties, including director fees and management fees primarily related to prior period services, amounted to US$67,000 during the quarter. This includes fees paid to Israel-based non-executive directors.
Outlook and Strategic Focus
Looking ahead, NGS enters the second half of FY26 with a permanently lower cost base, a debt-free balance sheet, and fully replenished inventory. The company is focused on completing the Sprout Organic acquisition and converting the enlarged customer base into revenue growth. Management expects approximately A$870,000 in annualised cost savings from operational integration and corporate rationalisation following completion.
Interim CEO Manik Pujara emphasised the strategic importance of the acquisition and capital raise, noting that these moves position NGS with enhanced operating leverage to translate growth into cash generation. The company aims to progress toward sustainable operating cash flow positivity as it executes on these initiatives.
Bottom Line?
NGS is poised for growth with a major acquisition and capital raise, but shareholder approval and successful integration remain key hurdles.
Questions in the middle?
- Will shareholder approval for the Sprout Organic acquisition and placement be secured without delay?
- How effectively can NGS integrate Sprout Organic to realise the projected A$870k in cost savings?
- Can the company sustain revenue growth and reduce operating cash outflows beyond the inventory investment phase?